Swissmedic
SAFETY ALERT
Changes to the Guidance document Drug Safety Signals HMP and the Signal Notification Form
Published: 2/1/2026Detected: 3/26/2026
Summary preview
Updates the Swissmedic framework for detecting, assessing, and reporting drug safety signals within the HMP by revising the associated guidance and the Signal Notification Form.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountOfficial Source Document Source Verified
Access the original document directly from SWISSMEDIC.
More from Swissmedic
- Extended deadline for publishing officially mandated information materials on the electronic publication platform11/12/2026
- Designer drugs: FDHA brings further psychoactive substances under control11/10/2026
- NAD+ supplements: When lifestyle products have criminal consequences11/9/2026
- Publication eCTD v4.0 Implementation Guide Package v2.011/9/2026
- Save the Date: Clinical Trials Symposium 202711/4/2026